Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2024Open Access

Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study

View Full Paper
Ask AI
Bookmark
Share

Authors

JJJongheon JungSJSung‐Hoon JungJLJe‐Jung Lee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jung et al. (2024) studied this question.

synapsesocial.com/papers/68e6cd0cb6db64358764aeb2https://doi.org/10.21203/rs.3.rs-4301217/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study2020 · 387 citations
  2. 2Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study2007 · 374 citations
  3. 3Frontline therapy for newly diagnosed patients with multiple myeloma2020 · 26 citations
  4. 4High-dose melphalan for multiple myeloma: long-term follow-up data.1994 · 102 citations
  5. 5Single <i>versus</i> tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase <scp>III GMMG</scp>‐<scp>HD</scp>2 trial2016 · 66 citations